The new findings published in the August issue of the Journal of Allergy and Clinical Immunology were conducted by researchers at the National Institute of Environmental Health Sciences (NIEHS) and the National Institute of Allergy and Infectious Diseases, both components of the National Institutes of Health.
A positive skin test result may mean the individual is more vulnerable to asthma, hay fever, and eczema. "Asthma is one of the world's most significant chronic health conditions," said David A. Schwartz, MD, the NIEHS Director. "Understanding what may account for the rising worldwide asthma rates will allow us to develop more effective prevention and treatment approaches."
NHANES III is a nationally representative survey conducted by the Centers for Disease Control and Prevention between 1988-1994 to determine the health and nutritional status of the U.S. population. Approximately 10,500 individuals participated in the skin testing. During these tests, skin was exposed to allergy-causing substances (allergens) and a positive test was determined by the size of the reaction on the skin. The 10 allergens tested include: Dust mite, german cockroach, cat, perennial rye, short ragweed, Bermuda grass, Russian thistle, White oak, Alternia alternata, and peanuts.
Researchers also compared skin test responses between NHANES III and the previous survey, NHANES II, conducted from 1976-1980. The prevalence of a positive skin test response was much higher in NHANES III than in NHANES II.
According to the lead author, Samuel J. Arbes, Ph.D. of NIEHS, "An increase in prevalence is consistent with reports from other countries and coincides with an increase in asthma cases during that time." In the U.S., the prevalence of asthma increased 73.9% from 1980 to 1996. However, Dr. Arbes was quick to point out that differences in skin test procedures between the two surveys prevent the authors from definitively concluding that the prevalence of skin test positivity has increased in the U.S. population.
"There is still much we don't understand about why some people become sensitized to allergens and others do not," said Darryl C. Zeldin, MD, senior author on the paper. "Much more research is needed in order for us to understand the complex relationships between exposures to allergens, the development of allergic sensitization, and the onset and exacerbation of allergic diseases such as asthma."
The researchers recently added an allergy component to NHANES 2005-2006. In addition to the other NHANES data collection components, dust samples from the homes of 10,000 individuals are being analyzed for allergens, and blood samples taken from these individuals are being examined for antibodies to those allergens. This new NHANES 2005-2006 allergy component will allow researchers to gain a greater understanding of asthma and the roles that indoor allergens play in asthma and other allergic diseases.
NIEHS, a component of the National Institutes of Health, supports research to understand the effects of the environment on human health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. For more information about allergens and other environmental health topics, please visit the NIEHS website at http://www.